BLSH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Bullish (BLSH) is not a good buy for a beginner, long-term investor at the moment. The stock is overvalued relative to peers, has weak financial performance, and lacks strong positive catalysts. Additionally, analysts have downgraded the stock, and there are no strong trading signals or influential trades to support a buy decision.
The MACD is positive and expanding, suggesting bullish momentum. However, the RSI is neutral at 71.758, and moving averages are converging, indicating no clear trend. The stock is trading near resistance levels (R1: 41.621), which could limit upside potential.
NULL identified. The stock lacks significant positive news or trading signals. The technical indicators show some bullish momentum, but it is not strong enough to warrant a buy.
Analysts have downgraded the stock citing overvaluation and risks to estimates. Financial performance is weak, with significant YoY declines in revenue, net income, EPS, and gross margin. Crypto market activity is collapsing, and legislative momentum for the CLARITY Act has stalled.
In Q4 2025, revenue dropped by -2.55% YoY to $64.35 billion. Net income plummeted by -445.95% YoY to -$546.6 million. EPS fell by -441.51% YoY to -3.62. Gross margin also declined by -25.00% YoY to 0.03, indicating significant financial weakness.
Recent analyst actions include downgrades and price target reductions. Rosenblatt downgraded the stock to Neutral with a $39 price target, citing overvaluation and risks to estimates. Other firms, including Citi and JPMorgan, have also reduced price targets, reflecting weak sentiment and concerns over the crypto market and legislative delays.
